CNK

Cinemark Holdings Inc

Add to Watchlist

Advanced Chart

25.445

+0.145(0.573%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

25.760

Open

25.480

VWAP

25.50

Vol

497.75K

Mkt Cap

2.91B

Low

25.310

Amount

12.69M

EV/EBITDA(TTM)

7.28

Total Shares

122.35M

4.44B

EV/OCF(TTM)

9.64

P/S(TTM)

1.15

Cinemark Holdings, Inc. is a movie theatre company. The Company is engaged in the motion picture exhibition industry, with theaters in the United States, Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, and Paraguay. Its segments include U.S. markets and international markets. Its circuit, comprised of various brands that also include Century, Tinseltown and Rave, operates approximately 497 theaters with 5,653 screens in 42 states domestically and 13 countries throughout South and Central America. It plays mainstream films from many different genres, such as animated films, family films, dramas, comedies, horror and action films. It offers content in both 2-D and 3-D formats in all of its theaters, and in many locations, it offers either its own premium large format, XD, IMAX or ScreenX. It offers a variety of alternative entertainment content for its guests, such as concert, sporting and gaming events, and others.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

636.82M

+17.78%

891.17M

+9.44%

863.42M

-6.33%

Estimates Revision

The market is revising Downward the revenue expectations for Cinemark Holdings, Inc. (CNK) for FY2025, with the revenue forecasts being adjusted by -1.44% over the past three months. During the same period, the stock price has changed by -16.08%.

Revenue Estimates for FY2025

Revise Downward

-1.44%

In Past 3 Month

Stock Price

Go Down

-16.08%

In Past 3 Month

9 Analyst Rating

38.85% Upside

Wall Street analysts forecast CNK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNK is 35.33 USD with a low forecast of 33.00 USD and a high forecast of 37.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

8 Buy

1 Hold

0 Sell

Strong Buy

38.85% Upside

Current: 25.445

Low

33.00

Averages

35.33

High

37.00

38.85% Upside

Current: 25.445

Low

33.00

Averages

35.33

High

37.00

Wells Fargo

Omar Mejias

Overweight

downgrade

$36 -> $33

2025-08-04

Reason

Wells Fargo

Omar Mejias

Price Target

$36 -> $33

2025-08-04

downgrade

Overweight

Reason

Wells Fargo analyst Omar Mejias lowered the firm's price target on Cinemark to $33 from $36 and keeps an Overweight rating on the shares. The firm notes the company continues to outperform industry results with strong execution plus growth in ATP/per caps. While the DBO has an air pocket in August/September, Wells expects the slate to accelerate into year-end. Wells believes Cinemark will become more aggressive with capital returns going forward.

Roth Capital

Buy

downgrade

$36 -> $34

2025-08-04

Reason

Roth Capital

Price Target

$36 -> $34

2025-08-04

downgrade

Buy

Reason

Roth Capital lowered the firm's price target on Cinemark to $34 from $36 but keeps a Buy rating on the shares after its Q2 results. The firm continues to view Cinemark as an attractive, defensive asset that is positioned within the 2 year window of positive content cycle, and while a softer Q3 is expected, there is growing optimism around a strong Q4 rebound leading into 2026, the analyst tells investors in a research note.

Wedbush

Alicia Reese

Neutral -> Outperform

upgrade

$32 -> $37

2025-07-11

Reason

Wedbush

Alicia Reese

Price Target

$32 -> $37

2025-07-11

upgrade

Neutral -> Outperform

Reason

Wedbush analyst Alicia Reese upgraded Cinemark to Outperform from Neutral with a price target of $37, up from $32.

Wedbush

Neutral -> Outperform

upgrade

$32 -> $37

2025-07-11

Reason

Wedbush

Price Target

$32 -> $37

2025-07-11

upgrade

Neutral -> Outperform

Reason

As previously reported, Wedbush upgraded Cinemark to Outperform from Neutral with a price target of $37, up from $32. The firm believes the company is poised to benefit from a more consistent release slate over the next several quarters, approaches its convertible debt repayment date next month, stays ahead of competitors with theater investments, and returns cash to shareholders in 2025 with a dividend and likely with shares repurchases.

Deutsche Bank

NULL -> Buy

initiated

$36

2025-07-10

Reason

Deutsche Bank

Price Target

$36

2025-07-10

initiated

NULL -> Buy

Reason

Deutsche Bank initiated coverage of Cinemark with a Buy rating and $36 price target.

Deutsche Bank

Bryan Kraft

Buy

initiated

$36

2025-07-10

Reason

Deutsche Bank

Bryan Kraft

Price Target

$36

2025-07-10

initiated

Buy

Reason

Deutsche Bank analyst Bryan Kraft initiated coverage of Cinemark with a Buy rating and $36 price target. The firm expects the volume of films released to theaters to continue to improve in the second half of 2025 and beyond. Cinemark is well positioned to grow its box office with a distinct footprint in both the U.S. and Latin America, the analyst tells investors in a research note.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Cinemark Holdings Inc (CNK.N) is 13.39, compared to its 5-year average forward P/E of 7.70. For a more detailed relative valuation and DCF analysis to assess Cinemark Holdings Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

7.70

Current PE

13.39

Overvalued PE

54.75

Undervalued PE

-39.35

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

14.91

Current EV/EBITDA

7.87

Overvalued EV/EBITDA

47.28

Undervalued EV/EBITDA

-17.45

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

0.89

Current PS

0.86

Overvalued PS

1.21

Undervalued PS

0.56

Financials

Annual

Quarterly

FY2025Q2

YoY :

+28.10%

940.50M

Total Revenue

FY2025Q2

YoY :

+108.16%

176.10M

Operating Profit

FY2025Q2

YoY :

+103.22%

94.70M

Net Income after Tax

FY2025Q2

YoY :

+96.88%

0.63

EPS - Diluted

FY2025Q2

YoY :

+52.48%

245.80M

Free Cash Flow

FY2025Q2

YoY :

+0.80%

58.18

Gross Profit Margin - %

FY2025Q2

YoY :

+25.60%

9.47

FCF Margin - %

FY2025Q2

YoY :

+58.58%

10.07

Net Margin - %

FY2025Q2

YoY :

+16.07%

14.88

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

1.7M

USD

3-6

Months

1.1M

USD

6-9

Months

6.2M

USD

0-12

Months

817.0K

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds areBuying! The buying amount has increased 101.37% over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

4.1M

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

3.6M

Volume

Months

6-9

1.8M

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

1.7M

USD

3-6

Months

1.1M

USD

6-9

Months

6.2M

USD

0-12

Months

817.0K

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

CNK News & Events

Events Timeline

2025-08-01 (ET)

2025-08-01

06:42:34

Cinemark reports Q2 EPS (32c) vs. 19c last year

2025-07-29 (ET)

2025-07-29

08:45:01

Largest borrow rate increases among liquid names

2025-07-16 (ET)

2025-07-16

18:17:29

Theater chains in talks about how to compete with Imax's screens, Bloomberg says

News

1.0

14:00 PMNewsfilter

CELEBRATE THE LANDMARK 30th ANNIVERSARY SEASON OF 'NOAH' WITH "SIGHT & SOUND® PRESENTS: NOAH--LIVE!" A SPECIAL FATHOM ENTERTAINMENT THEATRICAL ENGAGEMENT BEGINNING SEPTEMBER 18

6.5

08-05NASDAQ.COM

Analysts Expect IJR Will Reach $131

2.0

08-04Benzinga

Top 3 Tech And Telecom Stocks That Could Blast Off In Q3